Charles River Laboratories International

CRLNYSE United States Health Care Biotechnology: Commercial Physical & Biological Resarch

Market cap

$14.558 B

$304.96 -1.87%

Close of 7 Oct 2026

As of 7 Oct 2026, Charles River Laboratories International (CRL) has a market capitalization of $14.6B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$4.02B

#778 by revenue

Earnings

-$144.3M

Loss-making

Shares outstanding

47,738,872

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Commercial Physical & Biological Resarch, ranked by market cap

All 12 →

#2IncyteINCY$22.9B
#3MedpaceMEDP$16.8B
#4Charles River Laboratories InternationalCRL$14.6B
#5IconICLR$12.4B
#6AbsciABSI$1.76B

What if Charles River Laboratories International were worth as much as…

Open the what-if tool →

Gold $28.8T

$603,060.63

Per share 1,978× higher

Bitcoin $1.67T

$34,987.16

Per share 115× higher

Nvidia $5.77T

$120,775.46

Per share 396× higher

Or at a round number

$20.0B $50.0B $100.0B $200.0B

Where these numbers come from

Share counts and financials for Charles River Laboratories International are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 8 Oct 2026. Read the methodology.